PHOSPHATE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 931777
                    [Title] => Chronic kidney disease prevalent among Pinoys
                    [Summary] => 
In 2003, the Department of Health reported that the prevalence of chronic kidney disease (CKD) among adult Filipinos was 2.6 percent (or 2.6 out of 100 adult Filipinos).

                    [DatePublished] => 2013-04-18 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1302396
                    [AuthorName] => Eleanor Amarga
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 621297
                    [Title] => Bowel preps linked to phosphate nephropathy
                    [Summary] => 
The Food and Drug Administration has added a boxed warning to the prescription oral sodium phosphate bowel preparation products concerning the risk of acute phosphate nephropathy.
                    [DatePublished] => 2010-10-17 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Chronic kidney disease prevalent among Pinoys

By Eleanor Amarga | April 18, 2013 - 12:00am

In 2003, the Department of Health reported that the prevalence of chronic kidney disease (CKD) among adult Filipinos was 2.6 percent (or 2.6 out of 100 adult Filipinos).

Science and Environment

Bowel preps linked to phosphate nephropathy

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | October 17, 2010 - 12:00am

The Food and Drug Administration has added a boxed warning to the prescription oral sodium phosphate bowel preparation products concerning the risk of acute phosphate nephropathy.

Opinion